Tissue microarrays: Applications in urological cancer research

World Journal of Urology

Volumn 24, Issue 5, 2006, Pages 579-584

  Merseburger, A S ^a   Anastasiadis, A G ^a   Hennenlotter, J ^a   Schilling, D ^a   Simon, P ^b   Machtens, S A ^c   Serth, J ^c   Stenzl, A ^a   Kuczyk, Markus A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Carcinogenesis; Prognosis; Prostate cancer; Tissue microarray; TMA

Indexed keywords

TUMOR MARKER;

DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; PATHOLOGY; PROGNOSIS; PROTEIN MICROARRAY; REVIEW; TISSUE MICROARRAY; URINARY TRACT CANCER;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS;

EID: 33751238817     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-006-0103-1     Document Type: Review

References (25)

1. American Cancer Society (2004) http://www.cancer.org/docroot/STT/ stt_0_2003.asp?sitearea = STT&level = 1
2. Battifora H (1986) The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 55:244-248
3. Bova GS, Parmigiani G, Epstein JI, Wheeler T, Mucci NR, Rubin MA (2001) Web-based tissue microarray image data analysis: Initial validation testing through prostate cancer Gleason grading. Hum Pathol 32:417-427
4. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays [published erratum appears in Cancer Res 1999, 59(6):1388]. Cancer Res 59:803-806
5. Davis LD, Zhang W, Merseburger A, Young D, Xu L, Rhim JS, Moul JW, Srivastava S, Sesterhenn IA (2002) p63 expression profile in normal and malignant prostate epithelial cells. Anticancer Res 22:3819-3825
6. Halvorsen OJ, Haukaas SA, Akslen LA (2003) Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res 9:1474-1479
7. Hedberg Y, Ljungberg B, Roos G, Landberg G (2003) Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 88:1417-1423
8. Hotakainen K, Ljungberg B, Haglund C, Nordling S, Paju A, Stenman UH (2003) Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: Prognostic study on tissue and serum. Int J Cancer 104:631-635
9. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847
10. Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR, Dunn RL, Chinnaiyan AM, Rubin MA (2002) alpha-Methylacyl-CoA racemase: Expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 161:841-848
11. Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R (2003) P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 51:1097-1099
12. Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G (2003) Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 23:3413-3418
13. Looijenga LH, Stoop H, de Leeuw HP, Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244-2250
14. Manley S, Mucci NR, De Marzo AM, Rubin MA (2001) Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: The prostate specialized program of research excellence model. Am J Pathol 159:837-843
15. Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L, Connelly RR, McLeod DG, Mostofi FK, Srivastava SK, Stenzl A, Moul JW, Sesterhenn IA (2003) Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol Rep 10:223-228
16. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP (2002) Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62:1256-1260
17. Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A (2002) Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95:1247-1257
18. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G (2000) High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 157:787-794
19. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM (2002) alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287:1662-1670
20. Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G (2002) Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 21:2476-2483
21. Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M, Leighton X, Fehrle W, Pittaluga S, Raffeld M, Koivisto P, Willi N, Gasser TC, Kononen J, Sauter G, Kallioniemi OP, Srivastava S, Pollard HB (2001) ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 98:4575-4580
22. Visapaa H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A (2003) Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61:845-850
23. Visapaa H, Seligson D, Huang Y, Rao JY, Belldegrun A, Horvath S, Palotie A (2003) Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors. Urol Res 30:387-389
24. Visapaa H, Seligson D, Eeva M, Gaber F, Rao J, Belldegrun A, Palotie A (2003) 8q24 amplification in transitional cell carcinoma of bladder. Appl Immunohistochem Mol Morphol 11:33-36
25. Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L (2003) Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 55:20-29